|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Hospices Civils de Lyon |
|---|---|
| Information provided by: | Hospices Civils de Lyon |
| ClinicalTrials.gov Identifier: | NCT00308256 |
Purpose
The incidence of type 1 diabetes is increasing in France. A recent cross sectional study has shown that in France, only 15% of children and 26% of adults had HbA1c<7%. Adolescents seem to need particularly a better metabolic control.
Working Hypothesis:
We hypothesized that a stricter control of glycaemia by nurse-counselling could probably improve metabolic control in adolescents with type 1 diabetes.
Objectives:
To show that nurse-counselling may improve levels of patient satisfaction.
Methodology:
The main criterion is the patient acceptance of diabetes measured by an analogical visual scale rated from 0 (I cope very well with my diabetes, I cope very badly with my diabetes) to 10 cm. The scale will be measured every quarter within 12 months follow-up. We wish to improve patient's appreciation by 10 mm, near to "I cope very well with my diabetes". This is a randomised parallel group study with 36 subjects in each group. During the follow-up, the "routine follow-up" group will continue its routine care. The "complementary follow-up" group will be called by nurses every 15 days and consult monthly. HbA1c is the secondary criterion and will be measured every 3 months. The total study duration is 18 months including 6 months for the recruitment and 12 months for the patients follow-up
| Condition | Intervention |
|---|---|
|
Type 1 Diabetes |
Behavioral: nurse-counselling |
| Study Type: | Interventional |
| Study Design: | Randomized, Open Label, Uncontrolled, Parallel Assignment |
| Official Title: | Effects of Nurse-Counselling in the Improvement of the type1 Diabetes Control in Adolescents: a Randomized Controlled Trial |
| Estimated Enrollment: | 72 |
| Study Start Date: | March 2006 |
Eligibility| Ages Eligible for Study: | 13 Years to 18 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Marc NICOLINO, MD | 33 4 72 38 56 02 | marc.nicolino@chu-lyon.fr |
| France | |
| Marc Nicolino | Recruiting |
| Lyon, France, 69005 | |
| Contact: Marc Nicolino, MD 33 4 72 38 56 02 marc.nicolino@chu-lyon.fr | |
| Principal Investigator: | Marc NICOLINO, MD | Hospices Civils de Lyon |
More Information
| Study ID Numbers: | 2005.395 |
| Study First Received: | March 28, 2006 |
| Last Updated: | October 4, 2007 |
| ClinicalTrials.gov Identifier: | NCT00308256 History of Changes |
| Health Authority: | France: Ministry of Health |
|
Type1 diabetes; nurse-counselling; adolescent |
|
Autoimmune Diseases Metabolic Diseases Diabetes Mellitus, Type 1 Diabetes Mellitus Endocrine System Diseases |
Diabetes Mellitus Type 1 Endocrinopathy Glucose Metabolism Disorders Metabolic Disorder |
|
Autoimmune Diseases Metabolic Diseases Immune System Diseases Diabetes Mellitus, Type 1 |
Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders |